MSS51
Putative protein MSS51 homolog, mitochondrial
Also known as: FLJ39565, MSS51_HUMAN, ZMYND17
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4VC12
- Gene
- MSS51
- Ensembl
- ENSG00000166343
- Chromosome
- 10
- Canonical length
- 460 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
OverviewNCBI Gene
Predicted to enable zinc ion binding activity. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
460 residues, UniProt reviewed canonical sequence.
>Q4VC12|MSS51
1 MAPRSRRRRH KKPPSSVAPI IMAPTTIVTP VPLTPSKPGP SIDTLGFFSL DDNVPGLSQL
61 ILQKLNMKSY EEYKLVVDGG TPVSGFGFRC PQEMFQRMED TFRFCAHCRA LPSGLSDSKV
121 LRHCKRCRNV YYCGPECQKS DWPAHRRVCQ ELRLVAVDRL MEWLLVTGDF VLPSGPWPWP
181 PEAVQDWDSW FSMKGLHLDA TLDAVLVSHA VTTLWASVGR PRPDPDVLQG SLKRLLTDVL
241 SRPLTLGLGL RALGIDVRRT GGSTVHVVGA SHVETFLTRP GDYDELGYMF PGHLGLRVVM
301 VGVDVATGFS QSTSTSPLEP GTIQLSAHRG LYHDFWEEQV ETGQTHHPDL VAAFHPGFHS
361 SPDLMEAWLP TLLLLRDYKI PTLITVYSHQ ELVSSLQILV ELDTHITAFG SNPFMSLKPE
421 QVYSSPNKQP VYCSAYYIMF LGSSCQLDNR QLEEKVDGGILocalizationUniProt · AlphaFold · HPA
Whether an antibody against MSS51 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 245 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 245 nTPM
- parathyroid gland: 53 nTPM
- heart muscle: 10 nTPM
- tongue: 5.5 nTPM
- cerebellum: 5.4 nTPM
- spleen: 3.7 nTPM
Single-cell type
- myonuclei: 121 nCPM
- retinal ganglion cells: 16 nCPM
- fibro-adipogenic progenitors: 15 nCPM
- brain excitatory neurons: 15 nCPM
- adrenal cortex cells: 14 nCPM
- cardiomyocytes: 12 nCPM
Immune cell
- gdT-cell: 0.2 nTPM
- naive CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 14 nTPM
- cerebral cortex: 8.9 nTPM
- choroid plexus: 8.2 nTPM
- basal ganglia: 8.1 nTPM
- white matter: 7.6 nTPM
- amygdala: 7.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.38
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.55
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, MYND-type
- Mitochondrial splicing suppressor 51-like, C-terminal domain
- MYND finger
- MSS51 C-terminal domain
- Mitochondrial gene expression regulator
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MSS51 as an antibody target. Whether an autoantibody or antibody against MSS51 could matter depends on whether native MSS51 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MSS51 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MSS51 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...